Larazotide is a synthetic eight amino acid peptide that functions as a tight junction regulator and reverses leaky junctions to their normally closed state. It has been studied in people with coeliac disease. From Wikipedia
The phase IIa trial demonstrated rapid gastrointestinal symptom resolution alongside complete spike antigen clearance by day 21 in children treated with larazotide.
